Working… Menu
Trial record 1 of 1 for:    SIG-001-121
Previous Study | Return to List | Next Study

Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04541628
Recruitment Status : Suspended (Temporary enrolment halt)
First Posted : September 9, 2020
Last Update Posted : August 19, 2021
Information provided by (Responsible Party):
Sigilon Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : September 2026
Estimated Study Completion Date : September 2026